KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) FCF Margin (2016 - 2025)

Historic FCF Margin for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to 17.18%.

  • Bio-Rad Laboratories' FCF Margin rose 50000.0% to 17.18% in Q4 2025 from the same period last year, while for Dec 2025 it was 14.5%, marking a year-over-year increase of 32200.0%. This contributed to the annual value of 14.5% for FY2025, which is 32200.0% up from last year.
  • Bio-Rad Laboratories' FCF Margin amounted to 17.18% in Q4 2025, which was up 50000.0% from 13.66% recorded in Q3 2025.
  • Bio-Rad Laboratories' 5-year FCF Margin high stood at 26.2% for Q3 2021, and its period low was 2.43% during Q3 2022.
  • In the last 5 years, Bio-Rad Laboratories' FCF Margin had a median value of 10.09% in 2023 and averaged 11.0%.
  • As far as peak fluctuations go, Bio-Rad Laboratories' FCF Margin tumbled by -286400bps in 2022, and later surged by 114700bps in 2025.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' FCF Margin stood at 15.65% in 2021, then crashed by -61bps to 6.13% in 2022, then fell by -7bps to 5.69% in 2023, then surged by 114bps to 12.18% in 2024, then skyrocketed by 41bps to 17.18% in 2025.
  • Its last three reported values are 17.18% in Q4 2025, 13.66% for Q3 2025, and 10.87% during Q2 2025.